SERPINE1 and hyperinsulinemic hypoglycemia, familial, 4: To mitigate the bleeding risk associated with PAI-1 deficiency, antifibrinolytic therapy with TXA (20 mg/kg/day in two divided doses) was initiated as part of the management plan.